Live from the NIH registry
Studies recruiting near Ocala right now
Top 25 of 124 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
Multiple Myeloma (MM)
Phase 1
Interventional 258 participants sought
Ocala Oncology Center — Ocala, Florida (0.9 mi)
· Sponsor: Shanghai Henlius Biotech
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Lewy Body Dementia Psychosis
Phase 2
Interventional 180 participants sought
K2 Summit Research — Lady Lake, Florida (22.7 mi)
· Sponsor: ACADIA Pharmaceuticals Inc.
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Atherosclerotic Cardiovascular Disease (ASCVD)
Phase 3
Interventional 340 participants sought
Ocala Cardiovascular Research — Ocala, Florida (0.9 mi)
· Sponsor: Novartis Pharmaceuticals
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Phase 3
Interventional 582 participants sought
Research Site — Ocala, Florida (0.9 mi)
· Sponsor: AstraZeneca
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Florida Retina Institute Wildwood — Wildwood, Florida (22.6 mi)
· Sponsor: Boehringer Ingelheim
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 150 participants sought
Ocala Oncology Center /ID# 273697 — Ocala, Florida (0.9 mi)
· Sponsor: AbbVie
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Cognitive Dysfunction, Lewy Body Disease
Phase 2
Interventional 350 participants sought
Renstar Medical Research — Ocala, Florida (0.9 mi)
· Sponsor: Eli Lilly and Company
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
Idiopathic Pulmonary Fibrosis (IPF)
Phase 2
Interventional 359 participants sought
Research Site — Ocala, Florida (0.9 mi)
· Sponsor: AstraZeneca
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 410 participants sought
Local Institution - 1027 — Ocala, Florida (0.9 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Non-alcoholic Fatty Liver Disease
Phase 3
Interventional 1,200 participants sought
GSK Investigational Site — Ocala, Florida (0.9 mi)
· Sponsor: GlaxoSmithKline
A Study of Buntanetap in Participants With PD
Parkinson's Disease (PD), Deep Brain Stimulation
Phase 2, Phase 3
Interventional 500 participants sought
Renstar Medical Research — Ocala, Florida (0.9 mi)
· Sponsor: Annovis Bio Inc.
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Ocala, Florida (0.9 mi)
· Sponsor: Akero Therapeutics, Inc
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
Breast Cancer
N/A
Interventional 2,032 participants sought
Lake Medical Imaging — The Villages, Florida (20.4 mi)
· Sponsor: American College of Radiology
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Ocala, Florida (0.9 mi)
· Sponsor: DalCor Pharmaceuticals
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Acne
Phase 1, Phase 2
Interventional 800 participants sought
Renstar Medical Research - Ocala - Northeast 1st Avenue- Site Number : 8400021 — Ocala, Florida (0.9 mi)
· Sponsor: Sanofi Pasteur, a Sanofi Company
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 1,000 participants sought
Local Institution - 1040 — The Villages, Florida (20.4 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Breast Neoplasms, Carcinoma, Ductal, Breast
N/A
Interventional 725 participants sought
Ocala Oncology — Ocala, Florida (0.9 mi)
· Sponsor: Natera, Inc.
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Osteoarthritis, Knee, Diabetic Neuropathic Pain
Phase 2
Interventional 10,000 participants sought
Renstar Medical Research — Ocala, Florida (0.9 mi)
· Sponsor: Eli Lilly and Company
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
Small Cell Lung Cancer
Phase 2
Interventional 180 participants sought
Ocala Oncology Center /ID# 278269 — Ocala, Florida (0.9 mi)
· Sponsor: AbbVie
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Alzheimer Disease, Dementia
Phase 3
Interventional 550 participants sought
Charter Research - The Villages — The Villages, Florida (20.4 mi)
· Sponsor: Eli Lilly and Company
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Type 2 Diabetes
Phase 2
Interventional 240 participants sought
Renstar Medical Research — Ocala, Florida (0.9 mi)
· Sponsor: Eli Lilly and Company
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Chronic Obstructive Pulmonary Disease (COPD)
Phase 3
Interventional 990 participants sought
Research Site — Ocala, Florida (0.9 mi)
· Sponsor: AstraZeneca
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Early Alzheimer's Disease
Phase 2
Interventional 340 participants sought
Renstar Medical Research ( Site 1012) — Ocala, Florida (0.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
Lung Cancer Diagnosis
N/A
Observational 20,000 participants sought
Charter Research — The Villages, Florida (20.4 mi)
· Sponsor: Freenome Holdings Inc.
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Alzheimer's Disease
Phase 3
Interventional 586 participants sought
Renstar Medical Research — Ocala, Florida (0.9 mi)
· Sponsor: Bristol-Myers Squibb